Omega buys Allergopharma's allergy IVD assets; outlines sales growth strategy
This article was originally published in Clinica
Omega Diagnostics has conditionally agreed to acquire the IVD division of German allergy products developer Allergopharma Joachim Ganzer. The move paves the way for Omega's entry into the $3bn global allergy testing market, of which Swedish company Phadia is the leader.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.